These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

551 related items for PubMed ID: 18473303

  • 1. [Controversies about the use of calcineurin inhibitors in pediatric patients].
    Dello Strologo L.
    G Ital Nefrol; 2008; 25(3):317-24. PubMed ID: 18473303
    [Abstract] [Full Text] [Related]

  • 2. Long-term evaluation of cyclosporine and tacrolimus based immunosuppression in pediatric liver transplantation.
    Hasenbein W, Albani J, Englert C, Spehr A, Grabhorn E, Kemper MJ, Burdelski M, Ganschow R.
    Pediatr Transplant; 2006 Dec; 10(8):938-42. PubMed ID: 17096762
    [Abstract] [Full Text] [Related]

  • 3. The effect of long-term calcineurin inhibitor therapy on renal function in children after liver transplantation.
    Arora-Gupta N, Davies P, McKiernan P, Kelly DA.
    Pediatr Transplant; 2004 Apr; 8(2):145-50. PubMed ID: 15049794
    [Abstract] [Full Text] [Related]

  • 4. Is acute rejection the key predictor for long-term outcomes after renal transplantation when comparing calcineurin inhibitors?
    Nashan B.
    Transplant Rev (Orlando); 2009 Jan; 23(1):47-52. PubMed ID: 19027616
    [Abstract] [Full Text] [Related]

  • 5. Calcineurin inhibitors in heart transplantation.
    Keogh A.
    J Heart Lung Transplant; 2004 May; 23(5 Suppl):S202-6. PubMed ID: 15093806
    [Abstract] [Full Text] [Related]

  • 6. Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial.
    Schena FP, Pascoe MD, Alberu J, del Carmen Rial M, Oberbauer R, Brennan DC, Campistol JM, Racusen L, Polinsky MS, Goldberg-Alberts R, Li H, Scarola J, Neylan JF, Sirolimus CONVERT Trial Study Group.
    Transplantation; 2009 Jan 27; 87(2):233-42. PubMed ID: 19155978
    [Abstract] [Full Text] [Related]

  • 7. A numerical scale comparison of renal transplant recipient experience with and opinions about calcineurin inhibitors.
    Prasad GV, Nash MM, McFarlane PA, Zaltzman JS.
    Nephron Clin Pract; 2004 Jan 27; 97(2):c35-40. PubMed ID: 15218328
    [Abstract] [Full Text] [Related]

  • 8. Early renal benefit of rapamycin combined with reduced calcineurin inhibitor dose in pediatric heart transplantation patients.
    Balfour IC, Srun SW, Wood EG, Belsha CW, Marshall DL, Ferdman BR.
    J Heart Lung Transplant; 2006 May 27; 25(5):518-22. PubMed ID: 16678029
    [Abstract] [Full Text] [Related]

  • 9. [Low-toxicity immunosuppressive therapy in renal transplant].
    Scolari F, La Manna G, Comai G, Cappuccilli ML, Todeschini P, Ciavatti A, Persici E, Feliciangeli G, Stefoni S.
    G Ital Nefrol; 2007 May 27; 24 Suppl 38():44-8. PubMed ID: 17922447
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
    Yu S, He X, Yang L, Ma Y, Zhu X, Ju W, Huang J.
    Exp Clin Transplant; 2008 Jun 27; 6(2):113-7. PubMed ID: 18816237
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Tacrolimus based immunosuppression.
    First MR.
    J Nephrol; 2004 Jun 27; 17 Suppl 8():S25-31. PubMed ID: 15599882
    [Abstract] [Full Text] [Related]

  • 17. Calcineurin inhibitors in heart transplantation.
    Crespo-Leiro MG.
    Transplant Proc; 2005 Nov 27; 37(9):4018-20. PubMed ID: 16386614
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Sirolimus in liver transplant recipients with renal dysfunction offers no advantage over low-dose calcineurin inhibitor regimens.
    DuBay D, Smith RJ, Qiu KG, Levy GA, Lilly L, Therapondos G.
    Liver Transpl; 2008 May 27; 14(5):651-9. PubMed ID: 18433069
    [Abstract] [Full Text] [Related]

  • 20. Assessing the relative risk of cardiovascular disease among renal transplant patients receiving tacrolimus or cyclosporine.
    Jardine AG.
    Transpl Int; 2005 Apr 27; 18(4):379-84. PubMed ID: 15773954
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.